American Pharmed Labs -- APL -- Reports New Patent Allowed in United States for Treatment of Inner Ear and Labyrinth Symptoms.ENGLEWOOD CLIFFS, N.J.--(BUSINESS WIRE)--August 28, 1998--American Pharmed Labs Inc., a pharmaceutical company focusing on innovative pain relief therapies, today announced that the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property has issued a notice of allowance of APL's patent application for a method and composition of a topical treatment of inner ear and labyrinth symptoms. The patent claims a method for treating pathological symptoms of the inner ear and labyrinth, comprising administering to the periauricular region a topical carrier system with an active ingredient. "This patent allowance continues to build APL's substantial intellectual property portfolio for its products. Tinnitus Tinnitus Definition Tinnitus is hearing ringing, buzzing, or other sounds without an external cause. Patients may experience tinnitus in one or both ears or in the head. along with other inner ear problems represent an important medical need due to the lack of available pharmacologic approaches. Additionally, our estimates are that approximately 50 million individuals suffer from tinnitus alone in the United States," said Peter Golikov, Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of APL (A Programming Language) A high-level mathematical programming language noted for its brevity and matrix generation capabilities. Developed by Kenneth Iverson in the mid-1960s, it runs on micros to mainframes and is often used to develop mathematical models. . APL was established to develop novel therapies for treating mild to severe pain without systemic side effects Side effects Effects of a proposed project on other parts of the firm. . The company expects to introduce prescription and non-prescription products in the U.S. and Europe. APL's product development efforts are based on a new concept of pain control. In this concept, analogous to a "biological internet," pain is viewed as biological information that is transmitted through an interactive "neural network" connecting the peripheral nerves Peripheral nerves Nerves throughout the body that carry information to and from the spinal cord. Mentioned in: Amyloidosis, Charcot Marie Tooth Disease with the central nervous system. APL's products use local analgesics Analgesics Definition Analgesics are medicines that relieve pain. Purpose Analgesics are those drugs that mainly provide pain relief. as "neural firewalls," which block the transmission of pain information from peripheral nerves to the pain processing center in the brain cortex. The underlying approach to all of APL's products is the localized delivery of safe and proven analgesic analgesic (ăn'əljē`zĭk), any of a diverse group of drugs used to relieve pain. Analgesic drugs include the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, narcotic drugs such as morphine, and synthetic drugs agents. APL's proprietary products use its patented drug delivery technologies to release sustained doses of analgesic agents directly to terminal nerve receptors at the point of pain. Thus, pain relief may be achieved without the systemic effects associated with drugs that block pain by acting on the central nervous system. APL is based in Englewood Cliffs, N.J., and its research and development laboratories are located in Munich, Germany. More information about the company may be obtained from its Web site at www.apl-pain.com. CONTACT: American Pharmed Labs, Inc. Peter Golikov, Chief Operating Officer 201/894-8980 or B&Y Communications J.D. Solomon, 908/518-9383 Jennifer Passantino, 732/382-5912 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion